New antiepileptic drugs and preparations

Emergency Medicine Clinics of North America

Volumn 18, Issue 4, 2000, Pages 755-765

  Yoon, Young ^a   Jagoda, Andy ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DIAZEPAM; FELBAMATE; FOSPHENYTOIN SODIUM; GABAPENTIN; LAMOTRIGINE; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

AGED; APLASTIC ANEMIA; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG DOSAGE FORM; DRUG EFFECT; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG OVERDOSE; DRUG TOLERABILITY; EMERGENCY MEDICINE; EPILEPSY; FOCAL EPILEPSY; GERIATRIC CARE; HUMAN; LIVER TOXICITY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STEVENS JOHNSON SYNDROME;

EID: 0033646979     PISSN: 07338627     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8627(05)70157-7     Document Type: Article

References (40)

1. Rectal diazepam in pediatric status epilepticus
2. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetic mellitus: A randomized clinical trial
3. Recent advances in the pharmacotherapy of epilepsy
4. Advances in the medical treatment of epilepsy
5. Monotherapy trials of new antiepileptic drugs
6. New drugs for persons with epilepsy
7. New antiepileptic drugs
8. Pharmacokinetics of antiepileptic drugs
9. Efficacy of topiramate
10. Antiepileptic drugs
11. Treating repetitive seizures with a rectal diazepam formulation
12. International Gabapentin Monotherapy Study Group
13. Newer antiepileptic drugs: Gabapentin, lamotrigine, felbamate, topiramate and fosphenytoin
14. Intravenous Valproate Study Team
15. New antiepileptic drugs
16. Rectal diazepam for prehospital pediatric status epilepticus
17. Valproic acid and ethanol intoxication: Elevated blood levels with mild clinical effects
18. Experience with gabapentin overdose: Five case studies
19. Pharmacokinetics and interaction profile of topiramate
20. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984
21. The natural history of drug-resistant epilepsy: Epidemiologic considerations
22. Intravenous valproate treatment of generalized nonconvulsive status epilepticus
23. Topiramate: A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy
24. Antiepileptic medication interactions
25. Antiepileptic drugs in development: Prospects for the near future
26. Topiramate: A new antiepileptic drug
27. Safety review of adult clinical trial experience with lamotrigine
28. Lamotrigine overdose presenting as anticonvulsant hypersensitivity syndrome
29. Newer anticonvulsant drugs
30. Standard approach to antiepileptic drug treatment in the United States
31. Overview of lamotrigine and the new antiepileptic drugs: The challenge
32. Advances in the pharmacotherapy of epilepsy
33. Reflections on the treatment of seizures in the elderly population
34. Topiramate
35. Lamotrigine-induced severe cutaneous adverse reactions
36. Topiramate: Pharmacokinetics and pharmacodynamics
37. Overview of the safety of the newer antiepileptic drugs
38. New antiepileptic drugs
39. Seizures and epilepsy in the elderly
40. Lamotrigine in pregnancy and lactation: A case report